NCT00830830View on ClinicalTrials.gov

TREAD-20 Extension - Treatment of Knee Pain Due to Osteoarthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

October 31, 2006

Conditions
Osteoarthritis
Interventions
DRUG

Hyalgan (sodium hyaluronate)

Trial Locations (1)

08807

Sanofi-Aventis Inc, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00830830 - TREAD-20 Extension - Treatment of Knee Pain Due to Osteoarthritis | Biotech Hunter | Biotech Hunter